Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
I'm Ready to Subscribe
Special Offers
DNBi. Leverage D&B's credit assessment tools.

NovaMed, Inc. · Chicago, IL United States

Key NovaMed, Inc. Financials

Company TypePrivate -
Fiscal Year-EndDecember
2010 Sales (mil.)$151.8
2010 Employees772
For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now
Try A SubscriptionFree Report
Free Morningstar® Equity Research Report
Sign Up for Your 8-Page Report

NovaMed, Inc. Income Statement

Dec 10Dec 09Dec 08
Revenue 151.8 156.4 141.2
Cost of Goods Sold 36.8 35.6 32.6
Gross Profit 115.0 120.8 108.6
Gross Profit Margin75.7%77.2%76.9%
SG&A Expense 73.1 76.1 68.4
Depreciation & Amortization 5.0 5.9 4.3
Operating Income 36.9 38.8 35.9
Operating Margin24.3%24.8%25.4%
Nonoperating Income 0.3(0.0)(0.0)
Nonoperating Expenses(8.9)(8.8)--
Income Before Taxes 28.3 30.0 15.3
Income Taxes 4.4 4.8 6.0
Net Income After Taxes 23.9 25.2 9.3
Continuing Operations 23.9 25.2 9.3
Discontinued Operations(1.9)0.0 0.3
Total Operations 5.3 7.5 9.6
Total Net Income 5.3 7.5 9.6
Net Profit Margin3.5%4.8%6.8%
Diluted EPS from Total Net Income 0.68 0.96 1.14
Dividends per Share------
All amounts in millions of US Dollars except per share amounts.

NovaMed, Inc. Balance Sheet

AssetsDec 10Dec 09Dec 08
Current Assets
Cash 4.5 3.9 4.9
Net Receivables 21.7 22.4 20.8
Inventories 2.5 2.5 2.4
Other Current Assets 1.4 1.7 3.8
Total Current Assets 30.2 30.4 31.8
Net Fixed Assets 15.2 18.7 20.5
Other Noncurrent Assets 197.4 198.9 199.1
Total Assets 242.9 248.0 251.4
LiabilitiesDec 10Dec 09Dec 08
Current Liabilities
Accounts Payable 9.9 9.5 9.7
Short-Term Debt 25.1 8.2 3.3
Other Current Liabilities 5.4 5.5 6.7
Total Current Liabilities 40.4 23.3 19.7
Long-Term Debt 71.0 104.3 140.9
Other Noncurrent Liabilities 32.4 29.4 18.3
Total Liabilities 143.8 156.9 178.9
Shareholder's Equity
Preferred Stock Equity--0.0--
Common Stock Equity 99.1 91.0 72.5
Total Equity 99.1 91.0 72.5
Shares Outstanding (thou.)7,954.77,715.87,871.2
All amounts in millions of US Dollars except per share amounts.

NovaMed, Inc. Cash Flow Statement

Dec 10Dec 09Dec 08
Net Operating Cash Flow 41 44 25
Net Investing Cash Flow(2.0)(4.4)(55.4)
Net Financing Cash Flow(38.5)(40.7) 28.9
Net Change in Cash 0.6(1.0)(1.5)
Depreciation & Amortization 5.0 5.9 4.3
Capital Expenditures(1.5)(3.7)(4.9)
Cash Dividends Paid
All amounts in millions of US Dollars except per share amounts.